RoC Skincare announces the launch of the brand’s Derm Correxion® franchise with the first product from the line, RoC Derm Correxion Fill + Treat Serum. The serum will be showcased at this year’s American Academy of Dermatology (AAD) Annual Meeting, which takes place from March 25-29 in Boston.
RoC Derm Correxion Fill + Treat serum is a noninvasive wrinkle-filling treatment that targets the appearance of stubborn lines instantly and over time using a patent-pending 3D approach that works deep within skin’s surface, targeting all layers. Three forms of hyaluronic acid begin working right away to plump and fill the look of lines, while RoC Retinol works deep within the skin’s surface to support cell turnover and collagen to visibly reduce wrinkles.
Swertiamarin, an ingredient inspired by its use in the U.S. military to help treat damaged skin, supports the rebuilding of epidermal layers that are lost as people age. In clinical studies, 97% of users instantly had fine lines and wrinkles visibly plumped and filled, and within four weeks, 100% showed improvement in the look of hard-to-treat wrinkles, including crow’s feet, laugh lines and “11” lines (between the eyebrows).
“As a leader in retinol for decades, RoC continues to research and innovate on this gold standard of anti-aging, pushing the boundaries to provide lasting skin health and beauty benefits,” says Art Pellegrino, senior vice president of R&D at RoC Skincare. “With the launch of Derm Correxion, we are excited to leverage new data from our research on Retinol’s increased efficacy when formulated with hyaluronic acid.”
RoC Derm Correxion is the culmination of a multi-year research and development program in partnership with an advisory board of dermatologists and plastic surgeons: They include:
- Joshua Zeichner, MD, board-certified dermatologist, New York, N.Y.
- Anna Guanche, MD, FAAD, board-certified dermatologist, Calabasas, Calif.
- Melissa K. Levin, MD, FAAD, board-certified dermatologist, New York, N.Y.
- Sarmela Sunder, MD, double board-certified facial plastic surgeon, Beverly Hills, Calif.
- Wendy Lee, MD, professor of clinical ophthalmology & dermatology specializing in oculofacial plastic and reconstructive surgery, Miami
“We created this line as an affordable, accessible option for consumers to experience the instant benefits of a highly effective wrinkle-filling treatment. We are honored to have partnered with top skincare medical professionals in the field to bring our vision and our Brand’s dermatologist-recommended heritage to life,” says Fernando Acosta, CEO of RoC Skincare.